Andreas Bergner

Head of Computational Chemistry

Boehringer Ingelheim Pharmaceuticals Inc

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Cell Biology Cell Biology professors in Austria

About

Andreas Bergner is the Head of Computational Chemistry at Boehringer Ingelheim in Austria. His research primarily focuses on the discovery of targeted therapies for cancer, particularly in the context of HER2 inhibitors and β-Catenin. He has contributed to several significant publications addressing innovative methods in drug design and protein structure analysis.

Articles (5)

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andreas Bergner

Research Interests

Explore related searches

About

Articles (5)

Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling

Front Cover: Getting a Grip on the Undrugged: Targeting β‐Catenin with Fragment‐Based Methods (9/2021)

Getting a Grip on the Undrugged: Targeting β‐Catenin with Fragment‐Based Methods

Drugging All RAS Isoforms With One Pocket

A Grid Map Based Approach to Identify Nonobvious Ligand Design Opportunities in 3D Protein Structure Ensembles

Make your next move.